Xenetic Biosciences Correlations
XBIOWDelisted Stock | USD 17.54 0.00 0.00% |
The current 90-days correlation between Xenetic Biosciences and BioCardia is -0.01 (i.e., Good diversification). The correlation of Xenetic Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Xenetic Biosciences Correlation With Market
Average diversification
The correlation between Xenetic Biosciences and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Xenetic |
Moving together with Xenetic Stock
0.72 | KB | KB Financial Group | PairCorr |
0.71 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.73 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
0.64 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.86 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.72 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.78 | BAC | Bank of America Aggressive Push | PairCorr |
0.78 | HPQ | HP Inc | PairCorr |
0.75 | WMT | Walmart Aggressive Push | PairCorr |
0.77 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.79 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
Moving against Xenetic Stock
0.83 | EC | Ecopetrol SA ADR | PairCorr |
0.82 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.76 | TLK | Telkom Indonesia Tbk | PairCorr |
0.7 | HYMTF | Hyundai Motor | PairCorr |
0.66 | SHG | Shinhan Financial | PairCorr |
0.62 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
0.59 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.51 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.49 | TCHH | Trustcash Holdings | PairCorr |
0.47 | VFSWW | VinFast Auto | PairCorr |
0.41 | WF | Woori Financial Group | PairCorr |
0.39 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
0.45 | 0.38 | 0.5 | 0.66 | BCDAW | ||
0.45 | 0.5 | 0.43 | 0.29 | ARTLW | ||
0.38 | 0.5 | 0.68 | 0.44 | VERBW | ||
0.5 | 0.43 | 0.68 | 0.55 | ADILW | ||
0.66 | 0.29 | 0.44 | 0.55 | ENTXW | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Xenetic Stock performing well and Xenetic Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xenetic Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BCDAW | 17.63 | 1.62 | 0.06 | 3.01 | 18.27 | 57.25 | 139.50 | |||
ARTLW | 23.23 | 2.91 | 0.09 | (1.93) | 23.45 | 68.38 | 147.53 | |||
VERBW | 18.74 | 2.36 | 0.10 | 6.09 | 18.13 | 52.17 | 171.86 | |||
ADILW | 25.83 | 4.02 | 0.11 | (3.95) | 25.95 | 95.66 | 199.49 | |||
ENTXW | 37.20 | 5.71 | 0.19 | 0.61 | 30.23 | 135.48 | 266.82 |
Xenetic Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xenetic Biosciences stock to make a market-neutral strategy. Peer analysis of Xenetic Biosciences could also be used in its relative valuation, which is a method of valuing Xenetic Biosciences by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Xenetic Biosciences Corporate Executives
Elected by the shareholders, the Xenetic Biosciences' board of directors comprises two types of representatives: Xenetic Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xenetic. The board's role is to monitor Xenetic Biosciences' management team and ensure that shareholders' interests are well served. Xenetic Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xenetic Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
James Parslow | COO CFO | Profile |
Still Interested in Xenetic Biosciences?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.